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The lineage relationships of central–memory T cells (T
 
CM
 
) cells and effector–memory T cells 
(T
 
EM
 
), as well as their homeostasis and recall capacities, are still controversial. We investigated 
these issues in a murine model using two complementary approaches: T cell receptor 
repertoire analysis and adoptive transfer experiments of purified H-Y–specific T
 
CM
 
 and T
 
EM
 
 
populations. Repertoire studies showed that approximately two thirds of T
 
CM
 
 and T
 
EM
 
 clones 
derived from a common naive precursor, whereas the other third was distinct. Both 
approaches highlighted that T
 
CM
 
 and T
 
EM
 
 had drastically distinct behaviors in vivo, both in 
the absence of antigen or upon restimulation. T
 
CM
 
 clones were stable in the absence of 
restimulation and mounted a potent and sustained recall response upon secondary challenge, 
giving rise to both T
 
CM
 
 and T
 
EM
 
, although only a fraction of T
 
CM
 
 generated T
 
EM
 
. In contrast, 
T
 
EM
 
 persisted for only a short time in the absence of antigen and, although a fraction of 
them were able to express CD62L, they were unable to mount a proliferative response upon 
secondary challenge in this model.
 
Due to the persistence of memory T and B
lymphocytes and long-lived plasma cells, the
immune system is able to keep track of previ-
ously encountered pathogens and to give rise
to a rapid and efficient response in case of re-
encounter with the same pathogen (1, 2).
Memory T cells persist with an elevated fre-
quency and display enhanced functional capaci-
ties (3). Unfortunately, our knowledge of the
memory differentiation pathway is still limited,
which might explain why we fail to generate
efficient immune memory against some patho-
gens or other antigens such as tumor cells.
This difficulty may stem in part from the
heterogeneity of the memory T cell pool in
terms of phenotype, migration, and functional
capacities (3, 4). One recently recognized het-
erogeneity is the existence of memory cells re-
siding within peripheral tissues beside those re-
circulating between secondary lymphoid organs
(5). In humans, two subsets can be defined ac-
cording to their expression levels of CCR7 and
CD62L (6), both markers being necessary for
entry in peripheral lymph nodes through HEV
(7). The CCR7
 
 
 
CD62L
 
 
 
CD45RO
 
 
 
 central–
memory T cells (T
 
CM
 
) recirculate through lym-
phoid organs and do not display immediate effec-
tor functions, whereas the CCR7
 
 
 
CD62L
 
 
 
 cells
are effector–memory T cells (T
 
EM
 
) that reside
within, or recirculate through, peripheral tissues
and have immediate effector functions. All sub-
sets can be found in blood and in the spleen (6,
8, 9). T
 
CM
 
 and T
 
EM
 
 subsets can also be distin-
guished in mice depending on CD62L or
CCR7 expression levels (9, 10).
The distinction between the central– and
peripheral memory subsets raises two funda-
mental issues: (a) what is the relationship be-
tween these subsets? and (b) are both subsets
equally potent to generate a recall response?
Three models have recently been proposed re-
garding their relationship. The first one is the
“progressive differentiation model” (11) char-
acterized by three hallmarks. Depending on
the strength and duration of the stimulation
received by a naive T cell in the course of the
immune response, this cell will either follow
the differentiation pathway to acquire effector
functions to its end, or stop in an intermediate
differentiation state. Next, at the end of the
immune response, intermediates of differentia-
tion give rise to T
 
CM
 
, whereas T
 
EM
 
 stem from
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fully differentiated cells. Finally, in the absence of restimula-
tion, a proportion of T
 
CM
 
 differentiates into T
 
EM
 
 to replenish
the effector–memory pool. This model is supported by sev-
eral studies, both in humans and mice; only nonpolarized in
vitro–generated effectors recirculate in lymph nodes (8, 12),
and T
 
EM
 
 have a lower proliferative potential (9, 13) and en-
hanced effector functions (14–16), suggesting that T
 
EM
 
 are
more differentiated. Moreover, in the presence of IL-7 and
IL-15, both CD4 and CD8 T
 
CM
 
 were shown to generate
T
 
EM
 
 in vitro (17, 18).
In the second model, the two subsets also belong to one
lineage continuum, but it is the T
 
CM
 
 that derive from the
T
 
EM
 
, the latter being viewed as a transitory state (9, 19). The
rate at which these cells convert to T
 
CM
 
 depends on the
magnitude of the stimulation. Consistent with this model is
the observed patterns of gene expression during memory T
cell differentiation (20).
No mandatory lineage relationship between the two sub-
sets is assumed in the third model. In a previous study, we
analyzed the TCR repertoires of sorted T
 
CM
 
 and T
 
EM
 
 PB-
MCs in healthy donors and found that they were mainly dis-
tinct at a given time point. No conversion from one subset
to the other was observed over a 9-mo period (21). There-
fore, we suggested that both subsets could arise at least partly
independently, appearing in distinct secondary lymphoid or-
gans and/or under distinct primary stimulation conditions.
Alternatively, if most effector cells were to give rise to both
T
 
CM
 
 and T
 
EM
 
, at least one of these memory cell population
had to be transient or could not recirculate in the blood.
As a result, the differentiation pathway of T
 
CM
 
 and T
 
EM
 
subsets remains controversial, and additional complexity
arises concerning the self-renewal capacities of both subsets
or the conversion of cells from one subset to the other in
long-term steady-state conditions or upon restimulation (5).
The other key issue deals with the capacity of either sub-
set to mount a recall response. Several studies showed that
T
 
CM
 
 and T
 
EM
 
 may have the same effector capacities, in both
human or murine CD4 and CD8 T cells (22, 23), and that
T
 
CM
 
 may include fully differentiated effectors (24, 25).
However, others have suggested that T
 
CM
 
 and T
 
EM
 
 might
have differential protective capacities upon reencounter with
their cognate antigen. Indeed, although several papers sug-
gested that the presence of effector cells may be necessary for
protection against a peripheral challenge (26, 27), other stud-
ies highlighted the crucial role of T
 
CM
 
 in host defense (9, 14,
28). The comprehension of the respective roles of T
 
CM
 
 and
T
 
EM
 
 subsets in host protection in case of secondary challenge
is thus still limited and needs further investigation.
The study of lineage relationships requires the in vivo
production of measurable numbers of memory cells, which
is best achieved by the adoptive transfer of antigen-specific
naive T cells (29). Past studies have used TCR
 
  
 
 transgenic
T cells as a homogeneous source of naive T cells. However,
with this experimental design, it is impossible to determine
whether two memory cells would derive from a single or
two distinct naive precursors. To analyze the lineage rela-
tionships between T
 
CM
 
 and T
 
EM
 
 and their respective ability
to mount a recall response, we used a murine model en-
abling us to generate CD8 T
 
CM
 
 and T
 
EM
 
 subsets specific for
the H-Y male antigen with heterogeneous TCR. Mice
transgenic for the 
 
 
 
 chain of a D
 
b
 
-restricted Smcy3 peptide-
specific TCR were used as a source of CD8
 
 
 
 H-Y–specific
naive T cell precursors. These cells were transferred into
C57BL/6 naive female mice that were subsequently immu-
nized intravenously with male syngeneic bone marrow cells.
We have chosen this model for two reasons. First, the H-Y
antigen has been described as a nonpersistent and noncross-
reactive antigen (30). And second, fixing only the TCR
 
 
 
chain combines the advantages of making the TCR
 
 
 
 chain a
signature of each T cell clone and of restricting the reper-
toire of D
 
b
 
-Smcy3–specific CD8 T cells (31), which permits
a global study of the memory TCR
 
 
 
 repertoire.
We report here on the analysis of the TCR repertoires of
both subsets in lymphoid organs as well as peripheral tissues,
their evolution in steady-state conditions or after a secondary
challenge, and the fate of the transferred purified T
 
CM
 
 or
T
 
EM
 
 populations after this challenge.
 
RESULTS
In vivo generation of T CD8 memory subsets after 
intravenous immunization
 
First, we verified that we could generate measurable num-
bers of memory T cells of both subsets in our model. Naive
C57BL/6 female mice received 10
 
5
 
 CD8 naive T cells from
a female mouse transgenic for the 
 
 
 
 chain of TCR H-Y,
corresponding to 
 
 
 
3 
 
 
 
 10
 
4
 
 CD8 T cells specific for the H2-
D
 
b
 
–restricted Smcy3
 
738-746
 
 peptide (H-Y antigen; reference
31). The transferred mice were immunized intravenously
with 5 
 
 
 
 10
 
6
 
 male syngenic bone marrow cells (32), and we
used H2-D
 
b
 
-Smcy3 MHC tetramers to measure the immune
response in vivo. In peripheral blood, we observed a classical
T CD8 response beginning with an expansion of specific
CD8 cells, followed by a contraction phase prolonged by a
plateau that was maintained throughout the memory phase
(Fig. 1 A). Using CD45.1
 
 
 
 C57BL/6 mice as hosts, we
showed that the vast majority of D
 
b
 
-Smcy3–specific cells
generated derived from the transferred 
 
 
 
-tg CD45.2
 
 
 
 CD8
cells (see Fig. 4 C). CD62L expression by D
 
b
 
-Smcy3–spe-
cific PBLs cells was first down-regulated during the expan-
sion phase, almost all specific CD8 effector cells being
CD62L
 
 
 
 at the peak of the response. Next, the proportion
of CD62L
 
 
 
 cells steadily increased to reach approximately
half of the CD8 D
 
b
 
-Smcy3–specific population after 6 wk
and slowly continued to increase later on (Fig. 1 B). At 6
wk, we analyzed the presence of D
 
b
 
-Smcy3–specific cells in
lymphoid (blood, spleen, PLN, MLN) and peripheral (liver,
gut lamina propria) organs and their expression of the
CD62L molecule. D
 
b
 
-Smcy3–specific cells were present in
all organs analyzed (Fig. 1 C), and their percentage was
higher in peripheral organs such as liver or lamina propria.
We observed two subsets defined by their expression level of
CD62L (low/high) in all organs except lamina propria in 
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which virtually all cells displayed a CD62L
 
 
 
 phenotype.
Thus, our murine model was able to generate two subsets of
CD44
 
hi
 
 D
 
b
 
-Smcy3–specific CD8 memory cells defined by
their expression level of the CD62L molecule corresponding
to T
 
CM
 
 (CD62L
 
 
 
) and T
 
EM
 
 (CD62L
 
 
 
), allowing us to study
their TCR repertoires and their recall response capacities.
 
Repertoires of CD8 T
 
CM
 
 and T
 
EM
 
 in lymphoid and 
nonlymphoid organs are partly distinct
 
We sorted the D
 
b
 
-Smcy3–specific T
 
CM
 
 and T
 
EM
 
 subsets from
lymphoid (spleen, PLN, MLN) and peripheral (LP) organs
from C57BL/6 mice transferred with naive 
 
 
 
-tg CD8 cells and
immunized at least 6 wk before, and analyzed their TCR
 
 
 
repertoires. Having previously shown that most D
 
b
 
-Smcy3–
specific cells express a TCR
 
 
 
 chain using the TCRAV9 seg-
ment (31), we focused our analysis on TCRAV9-TCRAC re-
arrangements, which were sequenced extensively for splenic
T
 
CM
 
 and T
 
EM
 
 subsets sorted from several individual mice. Both
D
 
b
 
-Smcy3–specific subsets displayed a restricted repertoire
comprised of 
 
 
 
200 different clones. Moreover, the different
clones had a restricted usage of TCRAJ segments (Fig. S1 B,
available at http://www.jem.org/cgi/content/full/jem.
20040876/DC1) and displayed heterogeneous sizes, clone fre-
quencies ranging from 10
 
 
 
3
 
 to 10
 
 
 
1
 
 (Fig. S1 C).
Although it was difficult to identify every clone repre-
sented within a particular sample, we could estimate the rep-
ertoire diversity and overlap of both subsets using statistical
tools (see Materials and methods). Altogether, the TCR
 
 
 
repertoires of T
 
CM
 
 subsets were more diverse than those of
T
 
EM
 
, but only by a 1.5 factor (115 and 175 clones on aver-
age, respectively; Fig. S1 D). The low diversity observed im-
plied at least two consequences. First, because the number of
specific sorted cells analyzed by sequencing ranged between
6,000 and 27,000 cells, this sampling was large enough to
study a 
 
 
 
30-fold lower clonal diversity. Second, because we
transferred 
 
 
 
10
 
5
 
 transgenic cells per mouse, 
 
 
 
30% of which
were specific for the Smcy3 peptide, the presence of CD8
 
 
 
memory T cells with the same TCR in both subsets might
occur even if these cells were not derived from the same
stimulated naive T cell.
To measure this probability of artifactually shared clones
between the two subsets, we compared the repertoire over-
lap of T
 
CM
 
 and T
 
EM
 
 subsets from the same mouse (intraindi-
vidual overlap) or from two distinct mice (interindividual
overlap), using the observed percentages of shared clones
and the statistical overlap index (Table I and Fig. S1 E). The
interindividual percentages of shared clones were important
for both subsets (34.0 
 
 
 
 7.9% for TEM and 24.5   3.6% for
TCM), as well as the overlap index (0.38   0.03), showing
that a substantial sharing of clones between TCM and TEM
subsets could be attributed to the restricted diversity of the
Db-Smcy3–specific memory repertoire. However, intraindi-
Figure 1. In vivo generation of T CD8 memory subsets after intra-
venous immunization with male bone marrow cells of a C57BL/6 
female host transferred with naive  -tg CD8 cells. (A) Analysis of the 
percentage of Db-Smcy3  cells among CD8 PBLs for a naive C57BL/6 
mouse (open circles) or immunized hosts (closed squares). Data from 12 
mice were pooled. (B) Evolution of the percentage of CD62L  cells among 
CD8  Db-Smcy3  PBLs. (C) Analysis of the percentages and absolute 
numbers (in brackets) of Db-Smcy3–specific cells among CD8  cells in 
several organs 6 wk after immunization. (D) Expression of CD62L by CD8  
Db-Smcy3  cells in several organs at least 6 wk after immunization. FACS 
profiles are representative of all mice analyzed.IN VIVO BEHAVIOR OF CD8 TCM AND TEM | Bouneaud et al. 582
vidual percentages of shared clones were significantly higher
(55.4   7.4% for TEM and 38.6   4.7% for TCM), as was the
mean intraindividual overlap index (0.56   0.03). This indi-
cates that a significant proportion of the shared clones de-
rived from common naive precursor T cells. Taking into ac-
count the baseline percentage of sharing due to the restricted
diversity of the memory repertoire and the maximal percent-
age of sharing observable with our technology, we estimated
that two out of three clones were shared between the TCM
and TEM subsets (Fig. S1 E). Interestingly, most of the well-
represented clones were shared between the TCM and TEM
subsets (Fig. S1 C).
To confirm that the presence of unshared clones in the
subset repertoire was not due to an insufficient accumulation
of sequences, nor to sequestering of some clones within par-
ticular lymphoid or peripheral organs, and to have a broader
idea of the repartition of clones in the body, we measured by
quantitative clonotypic PCR the frequency of individual
clones in TCM and TEM subsets sorted from the spleen, PLN,
MLN, and LP from two individual mice transferred and im-
munized as described before (Fig. 2 and Fig. S2 B, available
at http://www.jem.org/cgi/content/full/jem.20040876/
DC1). Out of eight clones detected by sequencing, only in
the TCM or TEM subset, we confirmed that six of them were
readily detected in one subset only. In addition, this observa-
tion could be extended to other organs; when a clone was
present in one subset of the spleen only, it was either unde-
tected in other lymphoid organs, or remained within the
same subset in these organs.
Altogether, 6 wk after immunization, approximately two
thirds of total memory T cell clones were shared between
both subsets, so that TCM and TEM repertoires could be con-
sidered as only partly distinct. Clonotypic analyses confirmed
the presence of unshared clones and showed no sequestration
of clones in particular organs, suggesting that the situation
observed in the spleen was representative of the whole body.
Evolution of TCM and TEM TCR  repertoires in physiological 
conditions or after restimulation
This repertoire analysis was performed at a given time point.
It has been proposed that TEM can generate TCM (9) and vice
versa (17, 18). Therefore, we analyzed the stability of both
populations in the same mouse, with or without challenge.
For this purpose, we immunized mice after transfer of trans-
genic naive T cells as described before, and performed
hemisplenectomy 6 wk after immunization (T1), the other
spleen half being recovered 10 wk later (T2), with or with-
out a secondary intravenous immunization 4 wk after hemi-
splenectomy (Fig. 3 A). Thus, we could perform repertoire
analyses of both subsets on sorted specific splenocytes at two
time points distant of 10 wk. We extensively sequenced
TCRAV9-TCRAC rearrangements and analyzed the per-
centages of shared clones and the overlap indexes between
each mouse (four samples) with the aim of assessing possible
passages of clones between T1 and T2 from one subset to
the other. The only significant modification was observed in
the nonreimmunized mouse (Fig. 3 B). In that case, the per-
centage of shared clones between the TEM (T1) and TCM
(T2) subsets was significantly higher than that between TEM
(T1) and TCM (T1) subsets (78.3 vs. 53.0%). Accordingly,
the overlap index also increased (from 0.51 to 0.60). This
evolution strongly suggested that a sizable fraction of TEM
(T1) clones had reexpressed the CD62L molecule between
Table I. TCM and TEM clone sharing
Interindividual mean Intraindividual mean
Overlap index 0.38   0.03 0.56   0.03
% shared clones % shared clones
CD62L  24.5   3.6 38.6   4.7
CD62L  34.0   7.9 55.4   7.4
Total 16.5   3.1 29.3   3.9
Mean interindividual and intraindividual overlap indexes and percentages of shared 
clones for TCM, TEM, and total clones are displayed.
Figure 2. Frequency of individual clones in lymphoid and periph-
eral organs of an immune mouse. The frequency of each clone among 
TCRAV9  cells was measured by quantitative clonotypic PCR within each 
subset. An example of each type of clone (shared, unshared TCM, unshared 
TEM) is displayed. The frequency observed in the LP CD62L  subset for 
clone 132–8-31 corresponds to several cells  10 and, therefore, is con-
sidered as nonspecific amplification.JEM VOL. 201, February 21, 2005 583
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T1 and T2, also consistent with the observed increase of the
estimated diversity in the TCM subset from T1 to T2 (from
150 to 201 estimated clones), and with an increase of the
percentage of CD62L  cells among Db-Smcy3–specific
sorted cells (37% at T1 vs. 78% at T2). Interestingly, not all
cells of these TEM clones had apparently converted to a
CD62L  phenotype because the estimated diversity of the
TEM (T1) and TEM (T2) repertoires remained close (111 and
121, respectively).
To further analyze the possibility of TEM converting to a
CD62L  phenotype, we studied the fate of the clones found
at T1 in the TEM subset only (Fig. 3 C). In the absence of a
second challenge, most TEM (T1) unshared clones (82%) were
readily detected at T2, and 59% of these TEM (T1) unshared
clones appeared in the TCM subset, confirming that cells from
a substantial fraction of TEM (T1) clones had converted to a
CD62L  phenotype in the 10-wk interval, although most of
them were still present in the TEM (T2) subset. These obser-
vations were further confirmed by quantitative PCR clono-
typic analyses. We measured the frequency of five clones
present in the TEM subset at T1 (Fig. S2 C, top). Two of
them were only detected in the TEM subset at T1 and both
converted, at least partly, to a CD62L  phenotype in the ab-
sence of restimulation (Fig. 3 D, TEM→TCM and TEM). The
other three clones were already shared by both subsets at T1,
and two of them displayed a decrease of their frequency in
the TEM subset at T2, though without a corresponding in-
crease of their TCM frequency.
We also analyzed the fate of TEM (T1) unshared clones in
the reimmunized mouse. In contrast with what was observed
in the absence of restimulation, 50% of the unshared TEM
(T1) clones were no longer detected at T2, neither in the
TEM nor in the TCM subset, suggesting that a sizable fraction
of TEM (T1) clones had either migrated into peripheral tis-
sues or died.
Likewise, we investigated the possibility that some TCM
clones could acquire a TEM phenotype over time. We ana-
lyzed the variation of the percentage of shared clones be-
tween TCM (T1) and TEM clones. No significant difference
could be observed in both conditions (unpublished data),
which could receive two explanations: either TCM clones
were very stable and did not convert to TEM, or the TCM
clones that converted to TEM were already shared at T1. To
further analyze this point, we measured in both conditions
Figure 3. TCR  repertoire analysis of splenic Db-Smcy3–specific 
TCM and TEM subsets at two time points (T1 and T2), with or without 
a challenge in between. TCRAV9-TCRAC rearrangements were sequenced 
and analyzed. (A) Illustration of the experimental protocol. (B) In the non-
challenged mouse, evolution of the overlap index and of the percentage of 
shared clones between TEM (T1) and TCM at T1 and T2. (C) Evolution of TEM 
(T1) unshared clones at T2 in both conditions. (D and E) Evolution of the 
frequency of T1 unshared clones (D) in the absence of restimulation or (E) 
in the presence of an intravenous challenge. Frequencies were determined 
as in Fig. 2.IN VIVO BEHAVIOR OF CD8 TCM AND TEM | Bouneaud et al. 584
the frequency of several unshared TCM (T1) clones in both
subsets at T1 and T2 (Fig. S2 C). In the absence of restimu-
lation, out of six analyzed clones, five were stable and only
found in the TCM subset at T2 (the last one was undetectable
at T2 in both TCM and TEM subsets), which shows that TCM
clones were quite stable in the absence of restimulation (Fig.
3 D, TCM→TCM). In the reimmunized mouse, out of five
TCM (T1) unshared clones, four were stable in the TCM sub-
set at T2 (Fig. 3 E, TCM→TCM), whereas the last one gave
rise to TEM at T2 (Fig. 3 E, TCM→TCM and TEM), indicating
that the antigenic stimulation mainly drove already shared
TCM clones to differentiate into TEM clones, and that few
new clones appeared in the TEM subset upon restimulation.
This protocol using hemisplenectomies to analyze anti-
gen-specific TCM and TEM repertoires at two time points in
the same mouse in the presence or absence of a secondary
challenge thus enabled us to point out several features of the
fate of TCM and TEM in vivo. First, in the absence of antigen,
whereas TCM clones were quite stable, cells of  25% of the
observed TEM clones converted to a CD62L  phenotype.
Second, in the case of restimulation, TCM and TEM subsets
had a drastically different behavior; whereas TCM clones ei-
ther remained stable or gave rise to TEM, a majority of TEM
unshared clones at T1 disappeared.
TCM, but not TEM, can mount a recall immune response after 
an i.v. challenge
This last observation raised the question of the memory ca-
pacity of TEM. To refine our analysis of the properties of
TCM and TEM subsets, we examined their behavior after an
adoptive transfer in a new host, immediately followed by a
secondary intravenous immunization. At least 6 wk after the
primary immunization, we purified CD62L  and CD62L 
cells from the spleen and PLN of C57BL/6 hosts (Fig. S1 A).
Each of these populations containing 3   104 Db-Smcy3–
specific TCM or TEM was transferred into a new female
C57BL/6 host expressing the CD45.1 allele. These hosts
were immunized with 5   106 bone marrow cells from male
C57BL/6 CD45.1 mice and the Db-Smcy3–specific re-
sponse was followed by flow cytometry in blood.
When TCM were transferred, a rapid increase of the per-
centage of the CD45.2  transferred cells was observed in
blood (Fig. 4 A), correlated with the increase of the percent-
age of CD8  Db-Smcy3–specific cells (Fig. 4 B). This Db-
Smcy3–specific response was more rapid than that observed
in hosts after primary immunization of naive  -tg CD8 cells,
and was characteristic of a recall response. On the contrary,
when TEM were transferred, after a possible initial increase,
the percentage of CD45.2  transferred cells among host
Figure 4. TCM but not TEM can mount a recall response after transfer 
and challenge. CD62L  and CD62L  cells were purified from the spleen 
and PLN of hosts transferred with naive  -tg CD8 cells and immunized 
at least 6 wk earlier (see Materials and methods) and equal numbers of 
Db-Smcy3–specific TCM (closed symbols) or TEM (open symbols) were trans-
ferred into naive CD45.1  female hosts that were immediately immunized 
with syngeneic CD45.1  male bone marrow cells. (A) Evolution of the 
percentage of CD45.2  transferred cells among host blood CD8 cells. The 
percentage observed at day 2 is normalized as 100%, and all subsequent 
percentages are expressed as a percentage of this standard. (B) Analysis of 
the percentage of Db-Smcy3  cells among blood CD8 cells. (C) Expression 
of the CD45.2 molecule by CD8  Db-Smcy3  blood cells at day 15 or  1 mo 
after challenge, after transfer of naive, TCM, or TEM. (D) CD62L expression 
profiles and absolute numbers (in parentheses) of CD8  Db-Smcy3  cells 
in organs of a CD45.1  female host transferred with TCM and challenged at 
least 6 wk before analysis. All results shown are representative of at least 
three experiments.JEM VOL. 201, February 21, 2005 585
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CD8  cells dramatically decreased until these cells became
barely detectable (Fig. 4 A), in agreement with our conclu-
sion on the spleen repertoire study. However, a Db-Smcy3
response did occur in blood (Fig. 4 B), but it was due to the
CD45.1  naive cells of the host (Fig. 4 C). These results
were further extended to all organs analyzed after 6 wk. In
particular, the CD45.2  CD8  cells were barely detectable
in all organs analyzed including liver and gut lamina propria
when CD62L  cells had been transferred (unpublished data),
indicating that the decrease in the percentage of CD45.2 
cells observed in the blood was not due to their migration to
peripheral tissues, but most likely to their death.
The sequencing and clonotypic PCR studies performed
in the spleen at two time points with a secondary immuniza-
tion in between indicated that only a fraction of the TCM
clones could give rise to TEM clones after a secondary re-
sponse. However, this fraction was difficult to determine
from the hemisplenectomy experiments. Therefore, we ana-
lyzed the CD62L phenotype of the Db-Smcy3–specific
memory cells generated upon transfer with, and subsequent
challenge of, TCM. As shown in Fig. 4 D, the TCM trans-
ferred cells expanded and gave rise to both TCM and TEM in
the different organs analyzed. To determine the actual pro-
portion of the transferred clones that generated the TEM, we
sorted the Db-Smcy3–specific TCM and TEM splenic subsets
of two individual C57BL/6 CD45.1 hosts after transfer and
challenge, and analyzed their TCRAV9 repertoire. Once
again, the TCM subset repertoire was more diverse. More-
over, a majority of TEM clones (56   3%) had a counterpart
in the TCM subset, suggesting that most TCM clones that gave
rise to TEM also remained within the TCM subset. However,
only 47   7% of the TCM clones were also detected within
Figure 5. Adoptive transfer into naive hosts of CD62L    subsets 
purified from immune mice: overall TCM stability versus TEM death 
and partial CD62L reexpression. (A, B, and D) TCM and TEM were purified 
from spleen and PLN of immune hosts and transferred into naive female 
CD45.1 hosts. (A) Analysis of the persistence of CD8 CD62L    transferred 
cells 1 wk or  1 mo after transfer. The percentage of the CD45.2  trans-
ferred cells among CD8 compared with day 2 is displayed. Each circle rep-
resents an individual transferred host. The mean value is shown for each 
transferred population. (B) CD62L expression and absolute numbers (in 
parentheses) of CD8  Db-Smcy3 CD45.2  cells 6 wk after transfer of 
purified CD62L  cells. (C) Analysis of the propensity of TCM and TEM to un-
dergo apoptosis. CD62L    subsets were purified from the spleen and PLN 
cells from an old C57BL/6 mouse, and the expression of annexin V by 
CD8 CD44  cells was analyzed either directly ex vivo or after a 4-h stimu-
lation of both subsets with PMA and ionomycin. (D) Kinetic analysis of the 
percentage of CD62L  cells among CD8 CD44 CD45.2  cells in blood 
after transfer of CD45.2 CD62L  (closed circles) or CD45.2 CD62L  
(open circles) cells in a naive CD45.1 host. (E) CD62L expression profiles of 
CD8 CD45.2  remaining cells in various organs of a CD45.1 female host 6 
wk after transfer of CD62L  spleen and PLN cells sorted from an immune 
donor. (F) Naive CD45.1 female mice were transferred with CD45.2 CD62L  
cells, allowed to rest for various durations, and challenged with 5   106 
CD45.1  male bone marrow cells. Indicated for each duration are the 
number of mice analyzed, the percentage of transferred CD8 cells express-
ing CD62L, and the number of individual mice in which a host or a donor 
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the TEM subset, demonstrating that less than half of TCM
clones gave rise to TEM clones in case of restimulation (un-
published data).
These transfer experiments of purified CD62L  or
CD62L  memory cells showed that TCM and TEM had dras-
tically different behaviors in response to a secondary intrave-
nous immunization; whereas TCM mounted a secondary
response giving rise to an heterogeneous memory pool com-
prised of both TCM and TEM, TEM did not expand signifi-
cantly and were even less efficient than naive  -tg CD8 cells
to mount a proliferative Db-Smcy3–specific response.
In the absence of antigen, a proportion of TEM apparently 
convert to TCM but remain generally unable to mount 
a secondary response
The results of our splenocyte repertoire studies showed that,
in the absence of antigenic restimulation, a fraction of TEM
converted to a TCM phenotype. Here, we wanted to deter-
mine whether this conversion would be restricted to the
mere expression of CD62L, or would permit the converted
cells to regain the full capacity to respond as true TCM. We
used the same transfer model as for the analysis of TCM and
TEM recall capacities and monitored the evolution of the
percentage of the transferred population among CD8  cells
and its CD62L phenotype in blood in the absence of restim-
ulation. CD62L  cells persisted after transfer, with only a
slow decrease in the percentage of CD45.2  cells among
CD8 PBL cells with time (Fig. 5 A). Transferred CD8 
CD44  cells, as well as Db-Smcy3–specific cells, remained in
great majority CD62L  in all organs analyzed (Fig. 5 B and
not depicted).
When CD62L  spleen and PLN cells were transferred,
we observed a progressive decrease in the percentage of
CD45.2  transferred cells among CD8 PBLs with time,
which often became undetectable after 3 or 4 wk (Fig. 5 A).
This result and the fact that the transferred TEM were unable
to mount a recall response and disappeared within a few days
from reimmunized hosts suggested that they could have an
increased susceptibility to apoptosis. Thus, we analyzed the
propensity of purified CD62L    cells to undergo apoptosis
after in vitro stimulation. As shown in Fig. 5 C, the percent-
age of annexin V  cells among CD8 CD44  cells was al-
ready much higher in the CD62L  than in the CD62L 
population ex vivo. Moreover, contrary to CD62L CD8 
CD44  cells, the percentage of apoptotic annexin V  cells in
the CD62L  population increased significantly after a 4-h
stimulation, suggesting that the TEM subset comprised a sub-
population of memory cells that had an increased susceptibil-
ity to apoptosis in comparison to TCM.
The expression of the CD62L molecule by the trans-
ferred CD8 cells was altered with time. In blood, we ob-
served a progressive reexpression of the CD62L molecule
(Fig. 5 D). In some cases, when the transferred CD45.2 
cells persisted at detectable frequencies, we could analyze the
evolution of the CD62L phenotype in organs 6 wk after
transfer. Due to the already low percentage of transferred
cells, we performed our analysis on the total CD8  trans-
ferred TEM population. The CD8 CD45.2 CD62L profiles
obtained in various organs showed that a substantial fraction
of the persisting transferred CD8 cells were reexpressing
CD62L (Fig. 5 E). Moreover, although the percentage of
transferred CD8 cells in PLN was 1.61   0.7 and 2.11   0.7
times lower than in spleen and liver, respectively, some con-
verted CD62L  transferred cells even gained access to these
lymphoid organs. This suggested that, in the absence of anti-
gen, although a majority of TEM had died after a few weeks,
a fraction of them was able to progressively convert to TCM.
Next, we analyzed the capacity of the CD62L  con-
verted cells to mount an anamnestic response. We trans-
ferred the purified spleen and PLN CD45.2 CD62L   
populations into CD45.1  female hosts and intravenously
reimmunized these mice 2, 7, 15, or 30 d after transfer with
male CD45.1  bone marrow cells. We monitored the anti–
Db-Smcy3–specific response in PBLs (Fig. 5 F). For mice
transferred with CD62L  cells 2, 7, or 15 d before immuni-
zation, although respectively 26   7%, 19   7%, and 26  
7% of the transferred cells had converted to a CD62L  phe-
notype, the specific response observed after immunization
was always due to host naive cells. In some cases, we did
see a short and abortive proliferation of the transferred
CD8 CD45.2  cells. In five out of seven hosts transferred
30 d before immunization, the transferred cells had reached
an undetectable frequency on day 30 and a host-specific re-
sponse was observed after immunization. However, in the
two others, the transferred cells were still fully detectable at
day 30, although the percentage of CD62L  converted cells
among the CD8 CD45.2  cells was drastically different in
the two mice (35 vs. 91%). In both cases, a CD45.2  Db-
Smcy3–specific memory response was observed without a
substantial host response. These two mice were from distinct
experiments in which, although several other mice had been
transferred with the same batch of purified TEM, no other
donor response was observed.
Altogether, in contrast with TCM that can persist in the
absence of antigenic restimulation, most of the TEM were
susceptible to apoptosis, and the small fraction of cells that
could reexpress CD62L  were generally unable to mount a
secondary response.
DISCUSSION
TCM and TEM lineage relationships and homeostasis
The recent recognition that the CD8  T lymphocyte mem-
ory pool is heterogeneous raises the fundamental issue of lin-
eage relationship of TCM and TEM subsets, for which several
models have been proposed. In the model of independent
differentiation of TCM and TEM subsets, no relationship is as-
sumed between the two subsets; TCM and TEM could arise
independently, on a stochastic basis, based on precommit-
ment of the individual naive T cell, or depending on its
stimulation conditions. In the present work, the TCM and
TEM repertoires analyzed 6 wk after immunization were
partly distinct, some clones being found in one subset onlyJEM VOL. 201, February 21, 2005 587
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in all organs studied. This observation could be interpreted
as the result of an independent differentiation occurring in
particular locations or in response to some stimulation con-
ditions. The TCR affinity is probably not a discriminating
factor for this matter, as we observed no difference in TCR
affinity between TCM and TEM clones based on their TCR 
sequences (31). All stimulated cells appeared to display
TCR  sequences considered as high affinity (unpublished
data), and identical clones could be unshared TCM clones in
one host and unshared TEM clones in another one. Among
other factors, particular cytokine environments have been
shown to favor the differentiation of TCM or TEM in vitro (8,
12) and in vivo (33), and the stimulation of naive CD8  T
cells in the absence of CD4 help resulted in memory cells
with a TEM phenotype (34), indicating that particular stimu-
lation conditions could preferentially induce the differentia-
tion of TCM or TEM.
Our results clearly demonstrate that, during a systemic
immunization, approximately two thirds of the stimulated
naive clones can give rise to both TCM and TEM that are able
to coexist, at least transiently, in peripheral and lymphoid or-
gans, which argues against an exclusive model of indepen-
dent differentiation pathways for TCM and TEM. This sharing
percentage is much higher than that we had reported in a
previous paper on total PBL CD8  T CM and TEM human
subsets, although it was computed in a different way (21).
This variation can now be explained by the fact that we had
mainly analyzed whole human repertoires, irrespective of the
antigenic specificity, therefore a long time after memory has
probably been established for most antigens, and we know
from this and another paper that many TEM are able to regain
the CD62L expression with time (9). Also, subsequent im-
munizations with other antigens could differentially alter
TCM and TEM repertoires (35).
In the frequent case where a naive T cell generates both
TEM and TCM, three models can be proposed: the two cell
types could arise in parallel or sequentially, TEM giving rise to
TCM (9) or vice versa (17, 18). We were unable to detect any
significant production of TEM from TCM clones in the absence
of antigenic challenge, neither after hemisplenectomy nor us-
ing adoptive transfer. Indeed, in both approaches, the TCM
subset was very stable, consistent with the known persistence
of memory T cells in lymphoid organs (3). In the hemisple-
nectomy experiment, although we cannot rule out that the
shared TCM clones could produce TEM, the presence of un-
shared TCM clones indicates that at least some TCM clones did
not produce TEM. In addition, when we transferred purified
TCM into naive recipients, we were unable to detect any sig-
nificant number of TEM in the absence of restimulation. This
result challenges in vitro studies showing conversions of some
TCM clones to TEM in the presence of homeostatic IL-15 and
IL-7 cytokines (17, 18). There are two main possible expla-
nations: first, in these studies, inflammatory DC-derived cy-
tokines that could mimic inflammation mediated by a het-
erologous infection were added in most cases. Heterologous
immunity has been shown to affect memory homeostasis,
with consequences such as attrition and/or expansion of
cross-reactive T cells (35). Therefore, these conditions might
drive the differentiation of TCM clones into TEM, as was the
case here when TCM were challenged with male cells. Sim-
ilarly, we also observed some phenotype conversion of
non–Db-Smcy3–specific CD8 cells in mice transferred with
CD62L  cells and reimmunized with male cells, but it might
also be accounted for by other H-Y epitopes’ ongoing re-
sponses (32). Alternatively, this phenomenon of TCM conver-
sion to TEM in the absence of antigen could be a much slower
process in vivo compared with in vitro and we might have
observed it at later time point.
Strikingly, in the absence of challenge, cells from TEM
clones were shown to reexpress CD62L over a 10-wk pe-
riod, consistent with a recent paper (9). Although a high
proportion of TEM clones were implicated in this process, all
cells of these clones did not reexpress CD62L in a synchro-
nized manner, and most TEM clones found 6 wk after immu-
nization were still present in the TEM subset 10 wk later.
This is consistent with other papers showing an overall sta-
bility of the TEM subset in humans (6, 13, 15, 21), although
most of these studies were performed either on the total
memory population, independently of antigen specificity,
or in chronically infected patients. Moreover, despite the
persistence of TEM clonotypes over a 10-wk period in the
nonreimmunized mouse, the percentage of CD62L  cells
among total Db-Smcy3–specific sorted cells significantly in-
creased from T1 to T2 in this mouse, showing that the num-
ber of TEM globally decreased in the absence of restimula-
tion. This may in part stem from the reexpression of CD62L
by TEM but certainly also results from the general poor sur-
vival capacity of TEM that was observed after their adoptive
transfer into naive recipients.
Indeed, although our findings concerning TEM pheno-
typic conversion to TCM are in line with the results obtained
by Wherry et al., we found that only a fraction of the trans-
ferred TEM converted to a TCM CD62L  phenotype, whereas
many others were disappearing, probably because of apopto-
sis. These results are in agreement with several studies show-
ing a progressive decrease of nondividing TEM in peripheral
tissues (16, 26, 36) and others showing that the intrinsic abil-
ity of an effector T cell to differentiate into a memory T cell
is inversely correlated with its effector functions (37).
Overall, our results show that the differentiation process
of TCM and TEM is highly complex and heterogeneous and
that several features of the different proposed models have to
be taken into account. Indeed, although approximately two
thirds of TCM and TEM clones derive from a common naive
precursor, it is still possible that some TCM clones arise with-
out passing through a TEM stage, as suggested by the pres-
ence of unshared TCM clones and the higher repertoire
diversity of the TCM subset as early as 6 wk after immuniza-
tion. This would be in agreement with many studies sug-
gesting that TCM contain fewer differentiated cells (6, 13,
15). Concerning the stability of both subsets in vivo in the
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quite stable, both in terms of persistence and phenotype,
TEM can follow three different fates: death, persistence as
TEM, or conversion to a TCM phenotype (Fig. 6). Only a
fraction of these cells were prone to apoptosis, whereas the
remaining cells were able to survive for several weeks, even
upon transfer into a new host, therefore in the absence of
antigen. This threefold fate of TEM could be stochastic, only
a certain percentage of the TEM progeny of a naive precursor
being able to differentiate further into TCM. This could ex-
plain why a potent recall response was observed only in 2
out of 15 recipients transferred with purified TEM and im-
munized at least 7 d later, whereas in none of the other mice
transferred with the same batches of TEM was a donor re-
sponse observed. Alternatively, some particular exogenous
signals might be needed for a TEM to turn into a potent TCM.
In any case, for the TEM capable of converting to TCM, the
differentiation process appears to be progressive and the re-
expression of CD62L is probably only a first step. Indeed, al-
though a significant proportion of TEM transferred cells had
already converted to a CD62L  phenotype 2 d only after
transfer, no recall response of the transferred cells was ob-
served in any of the 14 animals that were transferred  30 d
before the challenge. This aspect is consistent with the fact
that the transcriptome of activated antigen-specific cells starts
stabilizing only 6 wk after immunization (20).
Respective roles of TCM and TEM
Our results show that most TEM have a short persistence in
vivo, which prompts the question of the real memory capac-
ity of these cells in vivo. In this work, TEM were less efficient
than TCM to eliminate the recall antigen, as reported recently
in another model (9). In particular, they were unable to
mount a sustained recall proliferative response. If they did
participate in the elimination of the male cells, their action
was certainly not potent enough so as to prevent any endoge-
nous primary host response to occur. However, despite their
inability to proliferate upon restimulation, TEM probably me-
diated some kind of memory (Fig. 6) because the host re-
sponse was somewhat attenuated in recipients transferred
with TEM compared with nontransferred ones or those trans-
ferred with naive T cells (Fig. 4 and not depicted), suggesting
that TEM provided a first effector wave to eliminate male
cells. It should be emphasized here that we only tested sple-
nocytes as a source of TEM, in combination with the intrave-
nous route for injection of a nonpathogenic antigen. There-
fore, we cannot exclude that the transfer of TEM  from
different peripheral tissues, such as LP TEM and/or the choice
of a pathogenic antigen, and/or its administration locally,
would lead to a different conclusion. Our model is more akin
to conditions that prevail for a systemic immunological re-
sponse against autologous virally infected or malignant cells.
The short-term memory role of the TEM could be a gen-
eral phenomenon, as several studies suggest that peripheral
TEM, and maybe recruited circulating TEM, do not divide in
peripheral infected tissue, but rather provide a first line of
defense against replication of the pathogen, the resolution of
the recall infection being mediated by new effector cells de-
rived from memory cells proliferating in the draining lymph
node (38). Moreover, although several studies have impli-
cated remaining effector or effector–memory cells in protec-
tion against some short-term secondary challenges, particu-
larly for local peripheral restimulations (26, 27), most data
point out the crucial role of TCM in secondary responses.
Similarly, we found that transferred TCM mounted a rapid
and sustained proliferative response upon secondary chal-
lenge, generating a large pool of secondary effectors that, af-
ter clearance of male cells, gave rise to a heterogeneous
memory population, comprised of both TCM and TEM.
However, this paper is the first to demonstrate that not all
TCM clones give rise to TEM after a secondary response in
vivo (Fig. 6) and that the TCM clones already shared after the
primary response may preferentially differentiate into TEM
upon secondary challenge.
Altogether, this paper provides new insights into the
drastically different behaviors of TCM and TEM CD8 subsets
in vivo and shows that vaccinologists should be careful not
to generate the maximum quantity of memory T cells, but
rather the right quality of memory cells, as was suggested re-
cently by Seaman et al. (33).
MATERIALS AND METHODS
Mice and immunizations. CD45.1  and CD45.2  C57BL/6 mice were
purchased from CDTA and Charles River Laboratories, respectively. Fe-
male mice transgenic for the   chain of the H-Y TCR ( -tg mice) were
raised in our animal facility. In these animals,  30% of the CD8 naive cells
are specific for the Db–Smcy3 complex (31). All animal experiments were
performed according to institutional guidelines for animal care and use.
For the generation of T CD8 memory cells, 105 female  -tg CD8 na-
ive cells containing  3   104 D b-Smcy3–specific CD8 cells were adop-
tively transferred into C57BL/6 female hosts, which were intravenously in-
Figure 6. Proposed model for the differentiation pathways of TCM 
and TEM after a primary response, in the absence of antigen, or in 
the case of antigenic restimulation. TCM are depicted as white cells and 
TEM are depicted as dark gray cells. The three possible fates of the latter are 
displayed. Light gray cells represent transitory TEM→TCM reexpressing 
CD62L but with various recall capacities depending on their position in the 
TEM→TCM differentiation pathway.JEM VOL. 201, February 21, 2005 589
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jected with 5   106 bone marrow cells from male syngeneic mice. All
studies were performed at least 6 wk after immunization.
Antibodies, peptides, and apoptosis detection. All antibodies used in
this study were purchased from BD Biosciences. Smcy3738-746 peptide and Db-
Smcy3 tetramers were described previously (31). For apoptosis experiment,
purified splenic CD62L  or CD62L  cells from C57BL/6 mice were triple
stained with anti-CD8 allophycocyanin, anti-CD44 Cychrome antibodies,
and annexin V solution (Boehringer) as recommended by the manufacturer,
either directly ex vivo or after 4-h culture with RPMI 1640 medium supple-
mented with 10% FCS, 50 ng/ml PMA, and 0.5  g/ml ionomycin.
Purification of TCM and TEM subsets. Lamina propria cells were pre-
pared as described previously (39). For repertoire analysis, splenic cells from
immunized mice were enriched in CD8 cells using MACS CD8 purification
kit (Miltenyi Biotec). Cells from all organs were stained with Db-Smcy3
tetramers, with anti-CD8–allophycocyanin and anti-CD44–Cy, and anti-
CD62L–FITC antibodies and CD8 Db-Smcy3 CD44 CD62L    (TCM/
TEM) cells were sorted on Moflo sorter (DakoCytomation). For functional
analyses and transfer experiments, splenic CD62L  and CD62L  subsets
were purified using the automacs (Miltenyi Biotec), either by staining cells
with anti-CD62L–allophycocyanin antibodies and anti-allophycocyanin mi-
crobeads, or directly with anti-CD62L microbeads. Purity data and represen-
tative CD62L expression profiles of sorted samples are provided in Fig. S1 A.
Transfer experiments. To analyze the behavior of TCM and TEM subsets
in the absence of antigen or in case of restimulation, purified spleen and
PLN CD45.2  CD62L    cells containing 3   104 CD8  Db-Smcy3–spe-
cific memory cells were transferred into CD45.1  C57BL/6 female mice.
For recall response experiments, these mice were injected intravenously
with 5   106 bone marrow cells from CD45.1  C57BL/6 male mice on
day 0, 2, 7, 15 or 30 after transfer of the purified CD62L    populations.
TCR  repertoire analysis. For sequencing analysis, TCRAV9-TCRAC
transcripts were amplified using TCRAV9.1-specific, 5 -GACACCGT-
TGTTAAAGGCACC-3 , TCRAV9.2-specific, 5 -GACGCCGTTGT-
TAAAGGCAC-3 , and TCRAC-specific, 5 -GGCACATTGATTTGG-
GAGTCA-3  primers; cloned; and sequenced as described previously (40).
For clonotypic quantitative analysis, real-time PCR was performed as
described previously (40) and in Fig. S2 A using the TCRAV9-specific
primers, the TCRAV9-specific nested Taqman probe TM_mTCRAV9
6-FAM-ACTCGGCCTCAAAGC-MGB, and either a nested TCRAC-
specific primer, 5 –CTGAGACCGAGGATCTTTTAACTGG-3  or one
of the clonotypic primers described in Fig. S2 (B and C).
Statistical analyses. To assess the repertoire diversity of a T cell subset, we
computed the abundance-based coverage estimator (41) with EstimateS soft-
ware (http://purl.oclc.org/estimates). We accumulated sequences until the
estimator reached a plateau. Representative curves for TCM and TEM sorted
populations are displayed in Fig. S1 D and show that, for most samples, the
estimator plateaued after 300–400 sequences. To estimate the repertoire
overlap between two populations, we computed the nonparametric maxi-
mum likelihood estimator (42). This index gives an estimation of the per-
centage of shared clones among the pooled TCM and TEM sequences, taking
into account their frequencies. Two controls were performed to normalize
these values (Fig. S1 E).
Online supplemental material. Fig. S1 illustrates the purification of
CD62L    subsets and the analysis of TCRAV9-TCRAC rearrangements
of sorted Db-Smcy3–specific TCM and TEM spleen cells. Fig. S2 illustrates
the analysis of individual clonotypes by quantitative PCR (Q-PCR). On-
line supplemental material is available at http://www.jem.org/cgi/content/
full/jem.20040876/DC1.
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